This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Veterinary Vaccines Market

Advances in Animal Immunization Development Technology Drive Up Demand for Veterinary Vaccines. FMI Tracks the Demand across 30+ Countries.

Veterinary Vaccines Market by Product, Disease, Distribution Channel, Species & Region | Forecast (2023 to 2033)

Veterinary Vaccines Market Outlook (2023 to 2033)

The net worth of the market share of veterinary vaccines is predicted to grow from US$ 11.3 Billion in 2023 to over US$ 20.82 billion by 2033. This is expected to further drive the market share of veterinary vaccines and register a CAGR of 6.2% between 2023 and 2033.

By controlling and preventing serious epidemic diseases, veterinary vaccines are often crucial to animal health protection. Throughout the forecast years, the veterinary vaccines market is expected to grow due primarily to the high adoption of pet animals across the globe.

This is due to increased expenditure on pet care, and increased adoption of efficient immunizations. For instance, Americans spent US$ 69.51 billion in 2017 on their pets, according to the Annual Industry-wide Spending Figures at the Global Pet Expo in Orlando, Florida.

In recent years, zoonotic diseases have become increasingly common and have led to a rise in interest in companion animal vaccines. A key factor contributing to advancement in this field is the emergence of new zoonotic diseases, government investments, and pet lovers' increased expenditures on animal health.

As a result of the development of novel vaccines that can target dangerous zoonotic diseases such as E. coli O157:H7. E. coli O157:H7 is a foodborne disease that can cause HUS and kidney failure. Veterinary vaccines have made a significant impact on human health, welfare, and production in recent years.

As a result of novel research in the field, the market for veterinary vaccines is expected to grow. This is because more vaccines are developed, adjuvants are developed, and pharmaceutical residuals are reduced in the human food chain.

In addition, the persistent economic slowdown, rising storage costs, and an increase in vegetarianism are significant factors limiting the market. With reduced costs, more investments in animal health, and skilled professionals, this market could have lucrative growth prospects.

Attributes

Details

Veterinary Vaccines Market Value (2023)

US$ 11.3 Billion

Veterinary Vaccines Market Expected Value (2033)

US$ 20.82 Billion

Veterinary Vaccines Market Projected CAGR (2023 to 2033)

6.2%

Customize this Report

Let us know your requirement to get
100% FREE customization

Global Veterinary Vaccines Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

Increasing Penetration of Animal Immunization Driving Market Expansion

The global veterinary vaccines market is forecast to grow a robust CAGR of 6.2% between 2023 and 2033 in comparison to 6.5% registered from 2017 to 2022. The rising prevalence of zoonotic diseases, increasing demand for animal products, growing trend of pet adoption across the world, and exponential growth of the animal healthcare products market are some of the key factors driving the global veterinary vaccines market.

Similarly, the rapid expansion of the veterinary respiratory disease treatment market and the veterinary pain management drugs market due to increasing spending by pet owners on improving the health of their pets will create sales prospects for veterinary vaccines throughout the forecast period.

Veterinary vaccines are gaining popularity for their ability to protect animal health as well as public health as they effectively mimic naturally acquired immunity. Veterinary vaccine sales are especially high across developed nations due to increasing pet ownership. These vaccines play a crucial role in assuring longevity and good health in animals.

  • Short Term (2022 to 2025): Growing efforts to develop vaccines for zoonotic diseases which are prevalent in humans as well, are set to enhance the growth of the overall veterinary vaccines market.
  • Medium Term (2025 to 2028): Spending on animals has increased substantially on account of rising pet adoption rates and growing awareness about maintaining the proper health of animals. Pet owners are spending large amounts on immunizing their pets. This will continue to push the demand for pet vaccines during the forecast period and will eventually expand the global veterinary vaccines market size.
  • Long Term (2028 to 2033): The introduction of technologically advanced vaccinations, increasing livestock population, rising government investments and initiatives to tackle the burden of animal diseases, and expanding pet care market across developing regions are expected to create growth avenues within the global veterinary vaccines market during the forthcoming years.
Historical CAGR (2016 to 2022) 6.5%
Historical Market Value US$ 10.7 Billion
Forecast CAGR 6.2%

Comparative Analysis of Adjacent Veterinary Vaccines Markets

Veterinary Vaccines Market:

Differentiating Aspects

Veterinary Vaccines Market

CAGR (2023 to 2033)

6.2%

Market Valuation in 2023

US$ 11.3 Billion

Projected Market Value in 2033

US$ 20.82 Billion

Growth Factors

Awareness and innovation of new inoculation products.

Opportunities

Rise in revenue due to increasing purchase of veterinary vaccines online

Key Trends

Technological advancement in animal immunization

Veterinary Therapeutics Market:

Differentiating Aspects

Veterinary Therapeutics Market

CAGR (2023 to 2033)

5.8%

Market Valuation in 2023

US$ 49.09 Billion

Projected Market Value in 2033

US$ 86.27 Billion

Growth Factors

Increasing demand for meat and other animal products.

Opportunities

A rise in the use of drugs in livestock animals and the approval of new products.

Key Trends

Increasing trend of preventive therapeutics designed to prevent the occurrence of a disease.

Animal Health Market:

Differentiating Aspects

Animal Health Market

CAGR (2023 to 2033)

6.3%

Market Valuation in 2023

US$ 56.33 Billion

Projected Market Value in 2033

US$ 103.76 Billion

Growth Factors

An increase in zoonotic diseases is expected to drive the market.

Opportunities

The potential for lucrative growth opportunities in veterinary medicine can be enhanced by increasing Research and Development (R&D) activities.

Key Trends

People are adopting pets for companionship at an increasing rate.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Factors are Shaping Veterinary Vaccines Market Growth?

  • Growing Importance of Developing Protozoan Parasitic Vaccines

The prevalence of a variety of animal diseases worldwide not only affects animals' health but is also dangerous for humans. For this reason, various governments are adopting mass vaccination programs for animals to stop disease transmission from animals to humans. This is expected to create significant demand for vaccines for national stockpiles.

Increasing initiatives and investments by governments around the world to tackle animal disease burden and ensure food security is anticipated to push the demand for veterinary vaccines in the future.

Currently, the veterinary healthcare industry is experiencing immense demand for protozoan parasitic vaccines and the trend is likely to escalate during the forecast period. Leading players have shifted their preference towards the production of third-generation DNA veterinary vaccines for protection against protozoan parasites due to their effective nature.

Consequently, the booming animal vaccines market worldwide will continue to create a conducive environment for veterinary vaccine suppliers during the forecast period.

  • Improving Access to Advanced and Effective Vaccines is Driving Market Growth

In addition, technological advancements and the subsequent launch of animal products are critical factors. Since animal immunizations were first introduced to the general public, they have undergone major R&D developments. In the field of animal and human health, vaccinations utilizing conventionally attenuated and inactivated pathogens have made significant and critical contributions.

Nevertheless, inactivated vaccines often can only partially mimic the drawbacks of traditional animal immunization, such as the complex immunogenicity of certain bacterial pathogens. Because of these factors, recombinant vaccines have been developed, which have many advantages, including not exposing the vaccine recipient to the pathogen during vaccination.

A further driving force behind the widespread adoption of animal inoculation products is the prevention of animal diseases that can be transmitted to humans and cause epidemics.

Which Restraining Factors are Impeding Growth in the Market?

Lack of Animal Vaccination Awareness Among Smallholder Farmers

Despite its optimistic stance, the global veterinary vaccines market is facing various challenges that are likely to slow down its growth during the forecast period. Some of these factors are the lack of awareness and accessibility for smaller farmers, low healthcare awareness in some regions, and the possibility of harmful outcomes of animal vaccinations. Similarly, the high

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Veterinary Vaccines Market Category-Wise Insights

Why is the Demand for Attenuated Live Vaccines Increasing?

Attenuated Live Vaccines Improving Public Health by Controlling Contagious Diseases

Attenuated live vaccines remain the most preferred product in the global veterinary vaccines market and are expected to account for 24.3% of the global market share in 2023. These vaccines are high in demand due to their strong, effective, and long-lasting nature.

Which Species Type Will Emerge as a Key Market Contributor?

Increasing Livestock Animal Immunization Creating Strong Demand for Veterinary Vaccines

In terms of species, livestock animals accounted for a major revenue share in the market due to the growing need for livestock animal immunization to assure the safety of food and dairy products.

Livestock animals are essential sources of primary and secondary food items that humans utilize in their daily routine’s life. Thus, ensuring proper health of these has become a top priority, thereby prompting farmers to use healthcare products like veterinary vaccines.

Similarly, the rapid growth of the animal vaccines market across developed and developing regions will further aid the growth in this segment.

Region-wise Analysis

What Makes North America an Attractive Market for Veterinary Vaccines?

Huge Demand for Pet Vaccines Across the Continent

North America continues to shape revenue generation in the global veterinary vaccines market due to an uptick in the usage of efficacious pet vaccines in tandem with tech-advanced vaccine delivery equipment, a rise in pet adoption rates, and rapid expansion of the animal vaccines market.

Furthermore, increasing awareness among consumers regarding the prevailing veterinary vaccine market trends is likely to favor the market in North America during the forecast period.

Countries Leading in Veterinary Vaccines Market: Country-Wise Analysis

What is the Demand Outlook for Veterinary Vaccines in the USA?

Advancements in Biotechnology and Veterinary Science to Drive Market Expansion

The USA will continue to be a prominent market for veterinary vaccines due to the increasing frequency of drug approvals, advances in veterinary science, rise in pet adoption rate, and the emergence of new veterinary vaccine market trends.

Similarly, increasing focus on innovation to avoid zoonotic diseases coupled with advancements in biotechnology and rapid growth of the animal healthcare market is expected to create a favorable platform for the development of veterinary vaccines in the USA

Why is Germany’s Veterinary Vaccines Market Considered Lucrative within Europe?

A Growing Number of Zoonotic Diseases are Driving Market Expansion

Germany held significant revenue across the forecast years with a stable growth rate. As a result of the increasing adoption of pet animals, a growing prevalence of zoonotic diseases, a growing number of veterinary clinics, and improved healthcare infrastructure in European countries, Germany is expected to hold the first leading revenue position in Europe.

How is the Market for Veterinary Vaccines Faring in China?

Growing Innovation of Veterinary Medical Devices to Fuel Growth

China is also emerging as an opportunistic market for veterinary vaccines, underpinned by collaborative initiatives of governments and private firms to promote better animal healthcare with advanced veterinary medical devices.

Livestock and companion animal owners across the country are showing a keen interest in following regular vaccination schedules, which is expected to push the veterinary vaccine sales in the country during the forecast period.

Start-up Ecosystem: The Veterinary Vaccines Market

In the past few years, veterinary vaccination has witnessed several technological advancements. Recombinant DNA technology has been used for several immunization products, including DNA vaccines.

As a result of novel technology, the stability of the drug has also been improved, and it is easier to administer the drug. Nucleic acid is an immunization technology that falls between the life and killed approaches.

Several key players are involved in the continuous advancement of product development tools to develop innovative and efficient veterinary vaccines based on DNA cloning into a delivery plasmid or direct injection of messenger RNA.

Competitive Landscape

Some of the prominent players in the veterinary vaccines market are as follows:

Recent Development: Large Scale Investment in R&D Activities for the Development of New Vaccines

Leading veterinary vaccine manufacturers are continuously investing in research and development activities for introducing effective vaccines. Besides this, they have adopted various market strategies such as joint ventures, collaborations, partnership agreements, sales agreements, and capacity expansion to expand their global footprint. For instance,

  • In January 2020, Merck Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA, and Automazioni VX Inc. introduced a newly designed subcutaneous chick vaccination technology called Innoject Pro.
  • In September 2020, Ceva Santé Animale increased its production capacity by three-fold for bacterial autogenous vaccines (primarily, for pigs and poultry) at its French plant.

Scope of Report

Attribute

Details

Forecast Period

2023 to 2033

Historical Data Available for

2018 to 2023

Market Analysis

US$ million for Value and MT for Volume

Key Regions Covered

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia

Key Countries Covered

The USA, Canada, Brazil, Mexico, Chile, Peru, Germany, The United Kingdom, Spain, Italy, France, Russia, Poland, China, India, Japan, Australia, New Zealand, GCC Countries, North Africa, South Africa, and Turkey

Key Segments Covered

  • Product
  • Disease
  • Distribution Channel
  • Species
  • Region

Key Companies Profiled

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, Drivers, Restraints, Opportunities and Threats Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Veterinary Vaccines Market Segmentation by Category

By Product:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

By Disease:

  • Anaplasmosis
  • Canine Parvovirus
  • Foot & Mouth Disease
  • New Castle Disease
  • Distemper Disease
  • Influenza
  • Porcine Reproductive & Respiratory Syndrome (PRRS)
  • Others

By Distribution Channel:

  • Veterinary Clinics
  • Veterinary Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies

By Species:

  • Companion Animals
    • Canine
    • Avian
    • Feline
  • Livestock Animals
    • Aquatic
    • Bovine
    • Porcine
    • Ovine/Caprine
    • Poultry
  • Equine

By Region:

  • North America
  • Latin America
  • Europe
  • The Middle East and Africa
  • East Asia

Frequently Asked Questions

The market size of the veterinary vaccines market in 2023 is US$ 11.3 billion.

North America is a lucrative veterinary vaccines market and is expected to dominate throughout the forecast period.

The global market of veterinary vaccines is projected to reach a valuation of US$ 20.82 billion by 2033.

Accounting for a 24.3% share, the attenuated live vaccines segment leads the veterinary vaccines market.

The global market of veterinary vaccines is projected to grow at approximately a CAGR of 6.2%.

Increased awareness among farmers, the rising transmission of zoonotic diseases, surging animal ownership, and new product launches will drive the adoption of veterinary vaccines.

Table of Content

1. Executive Summary | Veterinary Vaccines Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Species Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) Analysis By Species Type, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Species Type, 2023 to 2033

        5.3.1. Companion Animals

            5.3.1.1. Canine

            5.3.1.2. Avian

            5.3.1.3. Feline

        5.3.2. Livestock Animals

            5.3.2.1. Aquatic

            5.3.2.2. Bovine

            5.3.2.3. Porcine

            5.3.2.4. Ovine/Caprine

            5.3.2.5. Poultry

        5.3.3. Equine

    5.4. Y-o-Y Growth Trend Analysis By Species Type, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Species Type, 2023 to 2033

6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) Analysis By Product, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Product, 2023 to 2033

        6.3.1. Attenuated Live Vaccines

        6.3.2. Conjugate Vaccines

        6.3.3. Inactivated Vaccines

        6.3.4. Subunit Vaccines

        6.3.5. Toxoid Vaccines

        6.3.6. DNA Vaccines

        6.3.7. Recombinant Vaccines

    6.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Disease

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ million) Analysis By Disease, 2017 to 2022

    7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Disease, 2023 to 2033

        7.3.1. Anaplasmosis

        7.3.2. Canine Parvovirus

        7.3.3. Foot & Mouth Disease

        7.3.4. New Castle Disease

        7.3.5. Distemper Disease

        7.3.6. Influenza

        7.3.7. Porcine Reproductive & Respiratory Syndrome

        7.3.8. Others

    7.4. Y-o-Y Growth Trend Analysis By Disease, 2017 to 2022

    7.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033

8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ million) Analysis By Distribution Channel, 2017 to 2022

    8.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Distribution Channel, 2023 to 2033

        8.3.1. Veterinary Clinics

        8.3.2. Veterinary Hospitals

        8.3.3. Veterinary Research Institutes

        8.3.4. Retail Pharmacies

    8.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2022

    8.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023 to 2033

9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2022

    9.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Western Europe

        9.3.4. Eastern Europe

        9.3.5. Asia Pacific excluding Japan (APEJ)

        9.3.6. Japan

        9.3.7. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. The USA

            10.2.1.2. Canada

        10.2.2. By Species Type

        10.2.3. By Product

        10.2.4. By Disease

        10.2.5. By Distribution Channel

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Species Type

        10.3.3. By Product

        10.3.4. By Disease

        10.3.5. By Distribution Channel

    10.4. Key Takeaways

11. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Species Type

        11.2.3. By Product

        11.2.4. By Disease

        11.2.5. By Distribution Channel

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Species Type

        11.3.3. By Product

        11.3.4. By Disease

        11.3.5. By Distribution Channel

    11.4. Key Takeaways

12. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. The United Kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Nordic countries

            12.2.1.7. BENELUX

            12.2.1.8. Rest Of Western Europe

        12.2.2. By Species Type

        12.2.3. By Product

        12.2.4. By Disease

        12.2.5. By Distribution Channel

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Species Type

        12.3.3. By Product

        12.3.4. By Disease

        12.3.5. By Distribution Channel

    12.4. Key Takeaways

13. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. Russia

            13.2.1.2. Poland

            13.2.1.3. Rest Of Eastern Europe

        13.2.2. By Species Type

        13.2.3. By Product

        13.2.4. By Disease

        13.2.5. By Distribution Channel

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Species Type

        13.3.3. By Product

        13.3.4. By Disease

        13.3.5. By Distribution Channel

    13.4. Key Takeaways

14. APEJ Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. India

            14.2.1.3. ASEAN

            14.2.1.4. Australia & New Zealand

        14.2.2. By Species Type

        14.2.3. By Product

        14.2.4. By Disease

        14.2.5. By Distribution Channel

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Species Type

        14.3.3. By Product

        14.3.4. By Disease

        14.3.5. By Distribution Channel

    14.4. Key Takeaways

15. Japan Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

        15.2.2. By Species Type

        15.2.3. By Product

        15.2.4. By Disease

        15.2.5. By Distribution Channel

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Species Type

        15.3.3. By Product

        15.3.4. By Disease

        15.3.5. By Distribution Channel

    15.4. Key Takeaways

16. MEA Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2022

    16.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest Of MEA

        16.2.2. By Species Type

        16.2.3. By Product

        16.2.4. By Disease

        16.2.5. By Distribution Channel

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Species Type

        16.3.3. By Product

        16.3.4. By Disease

        16.3.5. By Distribution Channel

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. The USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Species Type

            17.1.2.2. By Product

            17.1.2.3. By Disease

            17.1.2.4. By Distribution Channel

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Species Type

            17.2.2.2. By Product

            17.2.2.3. By Disease

            17.2.2.4. By Distribution Channel

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Species Type

            17.3.2.2. By Product

            17.3.2.3. By Disease

            17.3.2.4. By Distribution Channel

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Species Type

            17.4.2.2. By Product

            17.4.2.3. By Disease

            17.4.2.4. By Distribution Channel

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Species Type

            17.5.2.2. By Product

            17.5.2.3. By Disease

            17.5.2.4. By Distribution Channel

    17.6. The United Kingdom

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Species Type

            17.6.2.2. By Product

            17.6.2.3. By Disease

            17.6.2.4. By Distribution Channel

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Species Type

            17.7.2.2. By Product

            17.7.2.3. By Disease

            17.7.2.4. By Distribution Channel

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Species Type

            17.8.2.2. By Product

            17.8.2.3. By Disease

            17.8.2.4. By Distribution Channel

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Species Type

            17.9.2.2. By Product

            17.9.2.3. By Disease

            17.9.2.4. By Distribution Channel

    17.10. Nordic countries

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Species Type

            17.10.2.2. By Product

            17.10.2.3. By Disease

            17.10.2.4. By Distribution Channel

    17.11. BENELUX

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Species Type

            17.11.2.2. By Product

            17.11.2.3. By Disease

            17.11.2.4. By Distribution Channel

    17.12. Russia

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Species Type

            17.12.2.2. By Product

            17.12.2.3. By Disease

            17.12.2.4. By Distribution Channel

    17.13. Poland

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Species Type

            17.13.2.2. By Product

            17.13.2.3. By Disease

            17.13.2.4. By Distribution Channel

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Species Type

            17.14.2.2. By Product

            17.14.2.3. By Disease

            17.14.2.4. By Distribution Channel

    17.15. India

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Species Type

            17.15.2.2. By Product

            17.15.2.3. By Disease

            17.15.2.4. By Distribution Channel

    17.16. ASEAN

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Species Type

            17.16.2.2. By Product

            17.16.2.3. By Disease

            17.16.2.4. By Distribution Channel

    17.17. Australia & New Zealand

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Species Type

            17.17.2.2. By Product

            17.17.2.3. By Disease

            17.17.2.4. By Distribution Channel

    17.18. Japan

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Species Type

            17.18.2.2. By Product

            17.18.2.3. By Disease

            17.18.2.4. By Distribution Channel

    17.19. GCC countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Species Type

            17.19.2.2. By Product

            17.19.2.3. By Disease

            17.19.2.4. By Distribution Channel

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Species Type

            17.20.2.2. By Product

            17.20.2.3. By Disease

            17.20.2.4. By Distribution Channel

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Species Type

            17.21.2.2. By Product

            17.21.2.3. By Disease

            17.21.2.4. By Distribution Channel

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Species Type

        18.3.3. By Product

        18.3.4. By Disease

        18.3.5. By Distribution Channel

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Boehringer Ingelheim GmbH

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. Zoetis Inc.

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Elanco Animal Health

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. Merck & Co., Inc.

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Bayer AG

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Virbac Group

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Ceva Santé Animale

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Phibro Animal Health Corporation

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Elanco 

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. HIPRA

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2033

Table 2: Global Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 3: Global Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 4: Global Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 5: Global Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 6: North America Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 7: North America Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 8: North America Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 9: North America Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 10: North America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 11: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 12: Latin America Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 13: Latin America Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 14: Latin America Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 15: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 16: Western Europe Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 17: Western Europe Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 18: Western Europe Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 19: Western Europe Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 20: Western Europe Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 21: Eastern Europe Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 22: Eastern Europe Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 23: Eastern Europe Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 24: Eastern Europe Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 25: Eastern Europe Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 26: APEJ Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 27: APEJ Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 28: APEJ Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 29: APEJ Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 30: APEJ Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 31: Japan Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 32: Japan Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 33: Japan Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 34: Japan Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 35: Japan Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Table 36: MEA Market Value (US$ million) Forecast by Country, 2017 to 2033

Table 37: MEA Market Value (US$ million) Forecast by Species Type, 2017 to 2033

Table 38: MEA Market Value (US$ million) Forecast by Product, 2017 to 2033

Table 39: MEA Market Value (US$ million) Forecast by Disease, 2017 to 2033

Table 40: MEA Market Value (US$ million) Forecast by Distribution Channel, 2017 to 2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Market Value (US$ million) by Species Type, 2023 to 2033

Figure 2: Global Market Value (US$ million) by Product, 2023 to 2033

Figure 3: Global Market Value (US$ million) by Disease, 2023 to 2033

Figure 4: Global Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 5: Global Market Value (US$ million) by Region, 2023 to 2033

Figure 6: Global Market Value (US$ million) Analysis by Region, 2017 to 2033

Figure 7: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 8: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 9: Global Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 10: Global Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 11: Global Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 12: Global Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 13: Global Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 14: Global Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 15: Global Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 16: Global Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 17: Global Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 18: Global Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 19: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 20: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 21: Global Market Attractiveness by Species Type, 2023 to 2033

Figure 22: Global Market Attractiveness by Product, 2023 to 2033

Figure 23: Global Market Attractiveness by Disease, 2023 to 2033

Figure 24: Global Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 25: Global Market Attractiveness by Region, 2023 to 2033

Figure 26: North America Market Value (US$ million) by Species Type, 2023 to 2033

Figure 27: North America Market Value (US$ million) by Product, 2023 to 2033

Figure 28: North America Market Value (US$ million) by Disease, 2023 to 2033

Figure 29: North America Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 30: North America Market Value (US$ million) by Country, 2023 to 2033

Figure 31: North America Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 32: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 33: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 34: North America Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 35: North America Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 36: North America Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 37: North America Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 38: North America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 39: North America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 40: North America Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 41: North America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 42: North America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 43: North America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 44: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 45: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 46: North America Market Attractiveness by Species Type, 2023 to 2033

Figure 47: North America Market Attractiveness by Product, 2023 to 2033

Figure 48: North America Market Attractiveness by Disease, 2023 to 2033

Figure 49: North America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 50: North America Market Attractiveness by Country, 2023 to 2033

Figure 51: Latin America Market Value (US$ million) by Species Type, 2023 to 2033

Figure 52: Latin America Market Value (US$ million) by Product, 2023 to 2033

Figure 53: Latin America Market Value (US$ million) by Disease, 2023 to 2033

Figure 54: Latin America Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 55: Latin America Market Value (US$ million) by Country, 2023 to 2033

Figure 56: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 57: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 58: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 59: Latin America Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 60: Latin America Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 61: Latin America Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 62: Latin America Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 63: Latin America Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 64: Latin America Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 65: Latin America Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 66: Latin America Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 67: Latin America Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 68: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 69: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 70: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 71: Latin America Market Attractiveness by Species Type, 2023 to 2033

Figure 72: Latin America Market Attractiveness by Product, 2023 to 2033

Figure 73: Latin America Market Attractiveness by Disease, 2023 to 2033

Figure 74: Latin America Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 75: Latin America Market Attractiveness by Country, 2023 to 2033

Figure 76: Western Europe Market Value (US$ million) by Species Type, 2023 to 2033

Figure 77: Western Europe Market Value (US$ million) by Product, 2023 to 2033

Figure 78: Western Europe Market Value (US$ million) by Disease, 2023 to 2033

Figure 79: Western Europe Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 80: Western Europe Market Value (US$ million) by Country, 2023 to 2033

Figure 81: Western Europe Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 82: Western Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 83: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 84: Western Europe Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 85: Western Europe Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 86: Western Europe Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 87: Western Europe Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 88: Western Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 89: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 90: Western Europe Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 91: Western Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 92: Western Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 93: Western Europe Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 94: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 95: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 96: Western Europe Market Attractiveness by Species Type, 2023 to 2033

Figure 97: Western Europe Market Attractiveness by Product, 2023 to 2033

Figure 98: Western Europe Market Attractiveness by Disease, 2023 to 2033

Figure 99: Western Europe Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 100: Western Europe Market Attractiveness by Country, 2023 to 2033

Figure 101: Eastern Europe Market Value (US$ million) by Species Type, 2023 to 2033

Figure 102: Eastern Europe Market Value (US$ million) by Product, 2023 to 2033

Figure 103: Eastern Europe Market Value (US$ million) by Disease, 2023 to 2033

Figure 104: Eastern Europe Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 105: Eastern Europe Market Value (US$ million) by Country, 2023 to 2033

Figure 106: Eastern Europe Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 107: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 108: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 109: Eastern Europe Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 110: Eastern Europe Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 111: Eastern Europe Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 112: Eastern Europe Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 113: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 114: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 115: Eastern Europe Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 116: Eastern Europe Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 117: Eastern Europe Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 118: Eastern Europe Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 119: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 120: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 121: Eastern Europe Market Attractiveness by Species Type, 2023 to 2033

Figure 122: Eastern Europe Market Attractiveness by Product, 2023 to 2033

Figure 123: Eastern Europe Market Attractiveness by Disease, 2023 to 2033

Figure 124: Eastern Europe Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 125: Eastern Europe Market Attractiveness by Country, 2023 to 2033

Figure 126: APEJ Market Value (US$ million) by Species Type, 2023 to 2033

Figure 127: APEJ Market Value (US$ million) by Product, 2023 to 2033

Figure 128: APEJ Market Value (US$ million) by Disease, 2023 to 2033

Figure 129: APEJ Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 130: APEJ Market Value (US$ million) by Country, 2023 to 2033

Figure 131: APEJ Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 132: APEJ Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: APEJ Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: APEJ Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 135: APEJ Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 136: APEJ Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 137: APEJ Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 138: APEJ Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 139: APEJ Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 140: APEJ Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 141: APEJ Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 142: APEJ Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 143: APEJ Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 144: APEJ Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 145: APEJ Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 146: APEJ Market Attractiveness by Species Type, 2023 to 2033

Figure 147: APEJ Market Attractiveness by Product, 2023 to 2033

Figure 148: APEJ Market Attractiveness by Disease, 2023 to 2033

Figure 149: APEJ Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 150: APEJ Market Attractiveness by Country, 2023 to 2033

Figure 151: Japan Market Value (US$ million) by Species Type, 2023 to 2033

Figure 152: Japan Market Value (US$ million) by Product, 2023 to 2033

Figure 153: Japan Market Value (US$ million) by Disease, 2023 to 2033

Figure 154: Japan Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 155: Japan Market Value (US$ million) by Country, 2023 to 2033

Figure 156: Japan Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 157: Japan Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 158: Japan Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 159: Japan Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 160: Japan Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 161: Japan Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 162: Japan Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 163: Japan Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 164: Japan Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 165: Japan Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 166: Japan Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 167: Japan Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 168: Japan Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 169: Japan Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 170: Japan Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 171: Japan Market Attractiveness by Species Type, 2023 to 2033

Figure 172: Japan Market Attractiveness by Product, 2023 to 2033

Figure 173: Japan Market Attractiveness by Disease, 2023 to 2033

Figure 174: Japan Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 175: Japan Market Attractiveness by Country, 2023 to 2033

Figure 176: MEA Market Value (US$ million) by Species Type, 2023 to 2033

Figure 177: MEA Market Value (US$ million) by Product, 2023 to 2033

Figure 178: MEA Market Value (US$ million) by Disease, 2023 to 2033

Figure 179: MEA Market Value (US$ million) by Distribution Channel, 2023 to 2033

Figure 180: MEA Market Value (US$ million) by Country, 2023 to 2033

Figure 181: MEA Market Value (US$ million) Analysis by Country, 2017 to 2033

Figure 182: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 183: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 184: MEA Market Value (US$ million) Analysis by Species Type, 2017 to 2033

Figure 185: MEA Market Value Share (%) and BPS Analysis by Species Type, 2023 to 2033

Figure 186: MEA Market Y-o-Y Growth (%) Projections by Species Type, 2023 to 2033

Figure 187: MEA Market Value (US$ million) Analysis by Product, 2017 to 2033

Figure 188: MEA Market Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 189: MEA Market Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 190: MEA Market Value (US$ million) Analysis by Disease, 2017 to 2033

Figure 191: MEA Market Value Share (%) and BPS Analysis by Disease, 2023 to 2033

Figure 192: MEA Market Y-o-Y Growth (%) Projections by Disease, 2023 to 2033

Figure 193: MEA Market Value (US$ million) Analysis by Distribution Channel, 2017 to 2033

Figure 194: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023 to 2033

Figure 195: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023 to 2033

Figure 196: MEA Market Attractiveness by Species Type, 2023 to 2033

Figure 197: MEA Market Attractiveness by Product, 2023 to 2033

Figure 198: MEA Market Attractiveness by Disease, 2023 to 2033

Figure 199: MEA Market Attractiveness by Distribution Channel, 2023 to 2033

Figure 200: MEA Market Attractiveness by Country, 2023 to 2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Middle East Veterinary Vaccines Market

Published : February 2022

Healthcare

Meningococcal Vaccines Market

Published : December 2021

Google translate

Veterinary Vaccines Market